Development and characterisation of a glutamate-sensitive motor neurone cell line.
about
Stabilization of the survival motor neuron protein by ASK1Rnf165/Ark2C enhances BMP-Smad signaling to mediate motor axon extensionImportant modifications by sugammadex, a modified γ-cyclodextrin, of ion currents in differentiated NSC-34 neuronal cellsMagnetic resonance and optical imaging probes for NMDA receptors on the cell surface of neurons: synthesis and evaluation in cellulo.Progranulin is expressed within motor neurons and promotes neuronal cell survivalDownregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/mTOR Signaling in NSC-34 Cells.Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.K(ATP) channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activationNeural cell type-specific responses to glycomimetic functionalized collagen.Transient mitochondrial permeability transition mediates excitotoxicity in glutamate-sensitive NSC34D motor neuron-like cellsα-COP binding to the survival motor neuron protein SMN is required for neuronal process outgrowthNSC-34 Motor Neuron-Like Cells Are Unsuitable as Experimental Model for Glutamate-Mediated Excitotoxicity.Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.Mitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of induced adaptive NO resistance in the CNS.Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen species: implications for multiple sclerosis.Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis.Electrochemical and optical sensing of reactive oxygen species: pathway to an integrated intracellular and extracellular measurement platform.Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging.Deep proteomic evaluation of primary and cell line motoneuron disease models delineates major differences in neuronal characteristics.Differentiated NSC-34 cells as an in vitro cell model for VX.Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.Down-regulation of apurinic/apyrimidinic endonuclease 1 (APE1) in spinal motor neurones under oxidative stress.Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis.Regulation of choline acetyltransferase expression by 17 β-oestradiol in NSC-34 cells and in the spinal cord.Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.Generation and validation of novel adeno-associated viral vectors for the analysis of Ca2+ homeostasis in motor neurons.Smn-Deficiency Increases the Intrinsic Excitability of Motoneurons.A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells.Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model.Tat-protein disulfide-isomerase A3: a possible candidate for preventing ischemic damage in the spinal cord.Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration.A Cystine-Rich Whey Supplement (Immunocal®) Provides Neuroprotection from Diverse Oxidative Stress-Inducing Agents In Vitro by Preserving Cellular Glutathione.Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
P2860
Q24299824-180DA59E-EF6C-4B6F-8449-7DCF9B100C98Q24338922-A68B9A6E-8094-491A-9FA5-6876D0DA76A8Q30366011-77D5B89F-3C6B-4D5A-9AB1-6F942A9839CCQ30860400-2D1E418D-9968-4B14-AD6D-216ED23900C0Q33513028-CB35926A-C816-432B-BE03-CDA72EB7D1FBQ33736536-5B3C0F93-DD69-4675-B140-1D144CB6B8D1Q33898352-D91837BA-60AA-4CC0-8F90-6ED5FE531EC8Q34571459-93E25180-1F78-4E00-8BBE-1B9391ADFEA6Q34990563-3C3A5ADB-6AAE-4641-A5AB-88A4E63F3AF5Q35576234-CB84E42E-F696-43FD-81DE-0F970026C326Q36101596-812E094A-B3FE-478A-BC7C-92D41A55B4BFQ36331590-FB3AD50C-2E97-4A8C-836D-40354A69096DQ36881384-EC4DC8D8-B3BB-4024-B323-7A7E42F71A89Q36890301-7E8071C3-46B3-4171-B706-28FA7ECB33DAQ37217374-6DDB3179-8DA8-428B-85A2-9AB289234FE7Q37217423-2563FD74-96F8-4E17-90A7-AC1F913720E8Q37373206-C6A9B2CB-D81C-47CC-AEB2-8EEA96EC3636Q37411790-74649AA0-0606-4B7D-88F3-E4229DECAC3BQ37706999-F10514A6-5124-429C-A7D6-6B7D819EBF4CQ37936514-01CA3149-B826-4743-9D46-2CD85AFCF501Q38160415-FA694326-0B28-4F76-9578-557629F9F317Q38811833-D4A0594F-6DD7-4681-9C7D-7909D56957DEQ38921294-FC7F0582-41E7-4A3D-9B56-F7CE820C0C8CQ38959386-6CCE9D46-ACC9-4C78-BCA9-CE32D7E268FAQ38973364-836CA206-CD25-4D3F-B9EE-DACE4CC2135FQ38989728-F37CBD9F-7DCE-4B70-B5A0-D7B48502247EQ39133838-CB20DA02-6C22-45D5-9928-363514BD01BFQ39217922-71863D67-4A0D-43D6-8DE9-3EC4B90E8BB9Q39500722-55879458-F367-4C16-9635-CBD25BEE6931Q39616472-2DF810B1-B2EB-4074-B1ED-AC01A6929698Q40106935-093DE863-48B9-485C-A688-E079EB2C25A4Q41450242-279AF695-5FF9-4AA5-93CF-B2EC5CCBB371Q41542370-C351E25F-E0D4-4448-84E2-A671CC14EFDFQ45881781-D3A335B5-777A-4257-AAE1-EB344A9EB887Q46294178-CEE3F53D-1A29-4F4D-9DAC-3CFB4495D243Q46891717-6E31E1FA-5810-4898-AC70-C6F2F4B00036Q47819640-78E1E42A-AC5A-4DD7-8912-388E537A1836Q52607544-5859B5E3-0895-464C-B1B6-212CAF3B520A
P2860
Development and characterisation of a glutamate-sensitive motor neurone cell line.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Development and characterisation of a glutamate-sensitive motor neurone cell line.
@en
type
label
Development and characterisation of a glutamate-sensitive motor neurone cell line.
@en
prefLabel
Development and characterisation of a glutamate-sensitive motor neurone cell line.
@en
P2093
P2860
P1476
Development and characterisation of a glutamate-sensitive motor neurone cell line.
@en
P2093
P2860
P304
P356
10.1046/J.1471-4159.2000.0741895.X
P407
P577
2000-05-01T00:00:00Z